Ciloa will be at the first Immunotherapies for Infectious Diseases Congress – I4ID, that will be held in Lyon (France) on December 11-12, 2017.
The emergence of new infectious diseases, the re-emergence of ancient infectious diseases, the rise of antibacterial resistance to conventional antibacterial agents and the difficulty to introduce and supply a new pipeline of novel antimicrobial compounds increases the interest for non-conventional approaches, such as immunotherapies as new therapies for Infectious Diseases.
